BVVL International was created in June 2008, and is the first web-based resource tool for physicians, researchers, and families interested in learning more about Brown-Vialetto-Van Laere syndrome. Brown-Vialetto-Van Laere syndrome (BVVL), sometimes referred to as “bulbar palsy,” is a rare, neurodegenerative motor neuron disorder, mainly affecting children. The disease causes a host of cranial nerve deficits including loss of the ability to speak, hear, swallow, and even breathe.
Present: The research with Kevin Eggan is ongoing. If you are interested in learning the most up to date aspects of this research, please feel free to contact us.
March 2016: The Thisbe and Noah Scott Foundation, Inc. granted to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University for a fourth year. Their groundbreaking discoveries have been documented in a recently published article in Human Molecular Genetics. See the BVVL Research Highlights page for more information.
March 4th, 2010: The first article outlining a BVVL gene was published. Since that time, other genes have been discovered that elucidate this disease as a riboflavin transporter gene mutation. See the BVVL Research Highlights page for more information.
November 26th, 2010: An article outlining a potential therapy for BVVL was published. Researchers continue to study intravenous B2 (riboflavin) therapy, which is effective for some patients. See the BVVL Research Highlights page for more information.
BVVL International is a resource for anyone interested in learning more about the disease and includes the following:
BVVL International is a project of the Thisbe and Noah Scott Foundation. Both got their start in 2008, by John and Laurian Scott, who lost their two children, Thisbe and Noah, to this devastating disease. The Scotts have worked with researchers across the world to find the gene that causes BVVL in the hopes to find a cure, so that no child or family will ever suffer the way that they have, and continue to, every single day.
As therapeutic progress continues for BVVL, the Scotts have expanded their mission to encompass all pediatric neuromuscular diseases. Find out more at http://www.thisbeandnoah.org/.